Daiichi Sankyo is a global pharmaceutical company based in Tokyo, Japan. The company focuses on research and development of innovative drugs to treat a range of medical conditions, including hypertension, blood clots, and cancer.
Founded in 2005 as a result of a merger between two Japanese pharmaceutical companies, Daiichi Sankyo has a history dating back to 1899.
Daiichi Sankyo has grown through a series of mergers and acquisitions, including the acquisition of German pharmaceutical company Nycomed in 2011.
The company has a global presence, with operations in over 20 countries.
Based in Tokyo, Japan, Takeda is a research-based global pharmaceutical company that develops and markets innovative medicines in various therapeutic areas, including oncology, gastroenterology, and neuroscience.
Based in Tokyo, Japan, Astellas is a pharmaceutical company that focuses on research, development, and marketing of drugs for a variety of medical conditions, including cancer, urology, and dermatology.
Based in Tokyo, Japan, Eisai is a pharmaceutical company that specializes in research and development of medicines for cancer, neurological disorders, and gastrointestinal diseases.
A medication used to prevent blood clots in patients with acute coronary syndrome, marketed in the US.
A medication used to treat hypertension, marketed in the US.
A drug used to treat HER2-positive breast cancer, marketed as Enhertu.
Daiichi Sankyo is based in Tokyo, Japan.
Daiichi Sankyo focuses on research and development of drugs to treat a range of medical conditions, including hypertension, blood clots, and cancer.
Effient is a medication used to prevent blood clots in patients with acute coronary syndrome.
Benicar is a medication used to treat hypertension.
Trastuzumab deruxtecan is a drug used to treat HER2-positive breast cancer, marketed as Enhertu.